NAMS Competitors & Alternatives
Compare NewAmsterdam Pharma Company N.V. Ordinary Shares with similar stocks in the same industry
Biotechnology
NAMS
Main Stock$31.40
Tradestie Score
50
Market Cap
$3.31B
Revenue Growth
0.0%
Analyst Upside
+57.0%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$98.25
|
$3.91B | - | 62 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$18.49
|
$3.83B | - | 54 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$17.01
|
$3.68B | - | 57 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$111.07
|
$3.67B | - | 58 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$8.69
|
$3.59B | 12.6 | 62 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$22.60
|
$3.58B | 10.0 | 65 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$279.44
|
$3.49B | 34.1 | 64 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$10.21
|
$3.40B | - | 55 | Compare |
|
QURE
uniQure N.V.
|
$49.04
|
$3.39B | - | 63 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$51.27
|
$3.33B | - | 62 | Compare |
More NAMS Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry